发明授权
EP2029591B1 SUBSTITUIERTE 4-ARYL-1,4-DIHYDRO-1,6-NAPHTHYRIDINE UND IHRE VERWENDUNG
有权
取代的4-芳基-1,4-二氢-1,6-萘啶及其用途
- 专利标题: SUBSTITUIERTE 4-ARYL-1,4-DIHYDRO-1,6-NAPHTHYRIDINE UND IHRE VERWENDUNG
- 专利标题(英): Substituted 4-aryl-1,4-dihydro-1,6-naphthyridines and use thereof
- 专利标题(中): 取代的4-芳基-1,4-二氢-1,6-萘啶及其用途
-
申请号: EP07725745.9申请日: 2007-06-01
-
公开(公告)号: EP2029591B1公开(公告)日: 2011-09-07
- 发明人: FIGUEROA PEREZ, Santiago , KOLKHOF, Peter , BÄRFACKER, Lars , FLAMME, Ingo , SCHLEMMER, Karl-Heinz , GROSSER, Rolf , MÜNTER, Klaus , KNORR, Andreas , NITSCHE, Adam
- 申请人: Bayer Pharma Aktiengesellschaft
- 申请人地址: Müllerstrasse 178 13353 Berlin DE
- 专利权人: Bayer Pharma Aktiengesellschaft
- 当前专利权人: Bayer Pharma Aktiengesellschaft
- 当前专利权人地址: Müllerstrasse 178 13353 Berlin DE
- 优先权: DE102006026585 20060607
- 国际公布: WO2007140934 20071213
- 主分类号: C07D471/04
- IPC分类号: C07D471/04 ; A61K31/4375 ; A61P9/00
摘要:
The present application relates to novel substituted 4-aryl-1,4-dihydro-1,6-naphthyridines, to processes for their preparation, to their use for treatment and/or prophylaxis of disorders and to their use for producing medicaments for treatment and/or prophylaxis of disorders, especially of cardiovascular disorders.
公开/授权文献
信息查询